Inspire Medical Systems, Inc. (INSP)

Inspire Medical Systems Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	175.42	185.54	441.59	214.47	190.52	22.86
Short-Term Investments	265.95	274.84	9.82	0	43.84	126.61
Cash & Cash Equivalents	441.36	460.38	451.41	214.47	234.36	149.47
Cash Growth	-2.37%	1.99%	110.48%	-8.49%	56.80%	-20.59%
Receivables	72.33	89.88	61.23	34.18	25.06	13.13
Inventory	48.97	33.89	11.89	17.23	8.48	5.83
Other Current Assets	9.55	9.6	5.51	2.66	1.97	2.21
Total Current Assets	572.21	593.74	530.03	268.54	269.87	170.64
Property, Plant & Equipment	74.53	62.65	24.13	16.41	11.12	3.96
Long-Term Investments	27.8	9.14	0	9.94	0	6.28
Other Long-Term Assets	11.3	11.28	10.72	0.2	0.2	0.38
Total Long-Term Assets	113.63	83.07	34.84	26.55	11.32	10.62
Total Assets	685.84	676.81	564.88	295.08	281.19	181.25
Accounts Payable	43.8	38.84	26.85	11.67	7.21	4.46
Current Debt	0	0	0	9.19	0	0
Other Current Liabilities	28.37	39.27	34.34	20.45	13.52	12.4
Total Current Liabilities	72.17	78.11	61.19	41.31	20.73	16.86
Long-Term Debt	24.5	24.85	7.54	24.6	30.63	24.52
Other Long-Term Liabilities	0.15	1.35	0.15	0.13	0.09	0.04
Total Long-Term Liabilities	24.65	26.19	7.68	24.73	30.72	24.56
Total Liabilities	96.82	104.3	68.87	66.04	51.44	41.42
Total Debt	24.5	24.85	7.54	33.78	30.63	24.52
Debt Growth	240.99%	229.70%	-77.69%	10.29%	24.92%	-1.62%
Retained Earnings	-355.43	-345.42	-324.27	-279.39	-237.35	-180.16
Comprehensive Income	0.12	0.8	-0.09	-0.06	0.03	0.1
Shareholders' Equity	589.02	572.51	496.01	229.05	229.75	139.84
Net Cash / Debt	416.86	435.53	443.88	180.68	203.73	124.94
Net Cash / Debt Growth	-6.30%	-1.88%	145.66%	-11.31%	63.06%	-23.48%
Net Cash Per Share	14.08	14.86	15.81	6.63	7.81	5.25
Working Capital	500.04	515.63	468.85	227.23	249.14	153.78
Book Value Per Share	19.89	19.54	17.67	8.40	8.81	5.87

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).